← All trials
NCT03060343
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 28, 2016
- Primary completion
- Nov 28, 2018
- Completion date
- Nov 28, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Central South UniversityLead sponsor
- Central South UniversityOverall official - principal investigator
- Hunan Zhaotai Yongren Biotech Co. Ltd.Overall official - principal investigator
- Central South UniversitySponsor investigator
- Hunan Zhaotai Yongren Biotech Co. Ltd.Collaborator
- Hunan Yongren Medical Innovation Co. Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.